• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

AstraZeneca expands Canada R&D work, to add 500 jobs

cafead

Administrator
Staff member
  • cafead   Feb 28, 2023 at 10:02: AM
via AstraZeneca will expand its Canada R&D footprint, expanding its center near Toronto and creating a new rare diseases research center there with its Alexion unit, the company said.

article source